Interestingly, the hazard ratio estimate for the association of the ovarian cancer PRS with ovarian cancer risk was statistically significantly higher for BRCA2 than for BRCA1 mutation carriers. The gene discussed is BRCA2; the disease is ovarian carcinoma.